| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/23/2003 | CA2453672A1 Root nodule bacteria having enhanced nitrogen-fixation ability |
| 01/23/2003 | CA2453574A1 Transgenic plants expressing cobalamin binding proteins |
| 01/23/2003 | CA2453566A1 Method and composition for inhibiting heparanase activity |
| 01/23/2003 | CA2453554A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 01/23/2003 | CA2453531A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 01/23/2003 | CA2453524A1 Methods and devices based upon a novel form of nucleic acid duplex on a surface |
| 01/23/2003 | CA2453496A1 Survivin interacting protein tpr1 |
| 01/23/2003 | CA2453494A1 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | CA2453489A1 Electrical field stimulation of eukaryotic cells |
| 01/23/2003 | CA2453438A1 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 01/23/2003 | CA2453435A1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor |
| 01/23/2003 | CA2453406A1 Methods for reducing immunogenicity of polypeptides |
| 01/23/2003 | CA2453405A1 Pseudotyped adeno-associated viruses and uses thereof |
| 01/23/2003 | CA2453362A1 Oligonucleotide-containing pharmacological compositions and their use |
| 01/23/2003 | CA2453360A1 Internal calibration standards for electrophoretic analyses |
| 01/23/2003 | CA2453357A1 Anti-neoplastic viral agents |
| 01/23/2003 | CA2453189A1 Bioassay for myostatin |
| 01/23/2003 | CA2453187A1 Production of transduced hematopoietic progenitor cells |
| 01/23/2003 | CA2453183A1 In vivo production of small interfering rnas that mediate gene silencing |
| 01/23/2003 | CA2453161A1 Lymphatic endothelial cells materials and methods |
| 01/23/2003 | CA2453136A1 Replikin peptides and uses thereof |
| 01/23/2003 | CA2452867A1 Allelic variants of gpr50 |
| 01/23/2003 | CA2452633A1 Nuclear fertility restorer genes and methods of use in plants |
| 01/23/2003 | CA2452605A1 Method of purifying nucleic acid using nonwoven fabric and detection method |
| 01/23/2003 | CA2452582A1 G-csf conjugates |
| 01/23/2003 | CA2452544A1 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 01/23/2003 | CA2452517A1 Recombinant vsv for the treatment of tumor cells |
| 01/23/2003 | CA2452417A1 Compositions comprising the biologicially active peptide ysl |
| 01/23/2003 | CA2452337A1 Use of specific t2r taste receptors to identify compounds that block bitter taste |
| 01/23/2003 | CA2450721A1 Method of elevating glutamic acid content in plant and plants having elevated glutamic acid content |
| 01/23/2003 | CA2449411A1 Human cytokine receptor |
| 01/23/2003 | CA2448517A1 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 01/22/2003 | EP1277843A2 Novel human genes and gene expression products related to colon cancer |
| 01/22/2003 | EP1277839A1 L-glutamate oxidase |
| 01/22/2003 | EP1277837A2 Epididymis-specific DNA sequences and their use |
| 01/22/2003 | EP1277836A1 Modulation of the IAPs and NAIP for the treatment of proliferative diseases |
| 01/22/2003 | EP1277835A1 Methods of creating genetic diversity |
| 01/22/2003 | EP1277833A2 Costal-2 homologue |
| 01/22/2003 | EP1277764A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/22/2003 | EP1277763A1 Polypeptides having larvae growth inhibiting or insecticidal effect on scarabaeidae insects and polynucleotides encoding the same |
| 01/22/2003 | EP1277762A2 Low allergenic protein variants |
| 01/22/2003 | EP1277464A2 Liposome coated with polyhydroxyalkanoate and production method thereof |
| 01/22/2003 | EP1277055A1 Biochip for the archiving and medical laboratory analysis of biological sample material |
| 01/22/2003 | EP1277050A2 Method of determining the three-dimensional shape of a macromolecule |
| 01/22/2003 | EP1276909A1 Method for mutation detection in hiv using pol sequencing |
| 01/22/2003 | EP1276907A2 Viral vectors for use in monitoring hiv drug resistance |
| 01/22/2003 | EP1276906A2 Medicine response assay in respiratory disease |
| 01/22/2003 | EP1276904A1 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
| 01/22/2003 | EP1276903A2 Method for determination of gene function |
| 01/22/2003 | EP1276902A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 01/22/2003 | EP1276900A2 Integrated systems and methods for diversity generation and screening |
| 01/22/2003 | EP1276897A2 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 01/22/2003 | EP1276896A2 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/22/2003 | EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 01/22/2003 | EP1276892A2 A bacterial two-hybrid system for protein interaction screening |
| 01/22/2003 | EP1276889A2 Sleeping beauty, a transposon vector with a broad host range for the genetic transformation in vertebrates |
| 01/22/2003 | EP1276888A2 Adenovirus vectors with knobless fibers, and their uses |
| 01/22/2003 | EP1276887A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 01/22/2003 | EP1276886A2 Method for the transformation of plant cell plastids |
| 01/22/2003 | EP1276885A2 Trophic conversion of obligate phototrophic algae through metabolic engineering |
| 01/22/2003 | EP1276884A2 Transgenic plants |
| 01/22/2003 | EP1276883A2 Amino acid:glyoxylate aminotransferase genes from plants and uses thereof |
| 01/22/2003 | EP1276882A2 Method for genetically modifying a plant |
| 01/22/2003 | EP1276881A2 Methods for enhancing the expression of a protein of interest by recombinant host cells |
| 01/22/2003 | EP1276880A2 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 01/22/2003 | EP1276879A1 MUIR-TORRE-LIKE SYNDROME IN Fhit DEFICIENT MICE |
| 01/22/2003 | EP1276878A2 Reversible immortalization |
| 01/22/2003 | EP1276877A2 Agent for postoperative use after the removal of bone tumours |
| 01/22/2003 | EP1276876A2 Expression-regulating sequences and expression products in the field of filamentous fungi: chrysosporium |
| 01/22/2003 | EP1276875A2 16835, a human phospholipase c and uses thereof |
| 01/22/2003 | EP1276874A1 Cloning and expressing an acid-resistant extracellular lipase of yarrowia lipolytica |
| 01/22/2003 | EP1276873A2 Human kinase proteins and polynucleotides encoding the same |
| 01/22/2003 | EP1276872A2 A thymus expressed human cytochrome p450 (p450tec) |
| 01/22/2003 | EP1276871A2 Enzyme variants having one or more d-amino acid substitutions |
| 01/22/2003 | EP1276870A1 Method for obtaining plants exhibiting enhanced resistance to water stress |
| 01/22/2003 | EP1276869A2 Methods and compositions to modulate expression in plants |
| 01/22/2003 | EP1276868A2 Identification of human gaba transporter |
| 01/22/2003 | EP1276867A2 Regulation of human latrophilin-like g protein-coupled receptor |
| 01/22/2003 | EP1276866A2 Novel compounds |
| 01/22/2003 | EP1276865A2 Methods for binding an exogenous molecule to cellular chromatin |
| 01/22/2003 | EP1276864A1 Primer for diagnosis of one or more kinds of cancer |
| 01/22/2003 | EP1276863A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/22/2003 | EP1276862A2 Heparanase ii, a human heparanase paralog |
| 01/22/2003 | EP1276861A2 Methods for modulating cellular and organismal phenotypes |
| 01/22/2003 | EP1276860A2 Databases of regulatory sequences; methods of making and using same |
| 01/22/2003 | EP1276859A2 Targeted modification of chromatin structure |
| 01/22/2003 | EP1276858A1 Non-pcr based recombination of nucleic acids |
| 01/22/2003 | EP1276857A1 Signal sequence trapping |
| 01/22/2003 | EP1276856A1 Albumin fusion proteins |
| 01/22/2003 | EP1276855A2 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 01/22/2003 | EP1276854A2 Extracellular expression of pectate lyase using bacillus or escherichia coli |
| 01/22/2003 | EP1276853A1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 01/22/2003 | EP1276852A2 Viruses comprising mutated ion channel protein |
| 01/22/2003 | EP1276850A2 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 01/22/2003 | EP1276849A2 Albumin fusion proteins |
| 01/22/2003 | EP1276770A1 Proteins with a high immunoreactivity and a method for the production thereof |
| 01/22/2003 | EP1276769A1 New neuromedin u receptor nmur2 and nucleotides encoding it |
| 01/22/2003 | EP1276766A2 G protein-coupled receptors |
| 01/22/2003 | EP1276765A2 Single-chain fertility hormones with variable lh activity |
| 01/22/2003 | EP1276764A1 Human polynucleotides, polypeptides, and antibodies |